Nano dimensions/adjuvants in COVID-19 vaccines-Reference-Cited by-同舟云学术

Nano dimensions/adjuvants in COVID-19 vaccines

Published:2022 Issue:10 Volume:10 Page:1520-1552
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Alphandéry Edouard¹²³^ORCID

Affiliation:

1. Sorbonne Université, Muséum National d'Histoire Naturelle, UMR CNRS 7590, IRD, Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie, IMPMC, 75005 Paris, France

2. Nanobacterie SARL, 36 Boulevard Flandrin, 75116, Paris, France

3. Institute of Anatomy, UZH University of Zurich, Instiute of Anatomy, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland

Abstract

A pictural representation showing that the combined contributions from the virology, nanotechnology and oncology fields can lead to an effective nano-vaccine against COVID-19.

Funder

NOMIS Stiftung

Association Nationale de la Recherche et de la Technologie

Agence Nationale de la Recherche

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D1TB02408F

Reference246 articles.

1. COVID-19 vaccines: The status and perspectives in delivery points of view